替考拉宁治疗耐甲氧西林金黄色葡萄球菌骨髓炎。 - Suppr

Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.

作者信息

Twilla Jennifer D, Gelfand Michael S, Cleveland Kerry O, Usery Justin B

出版信息

J Antimicrob Chemother. 2011 Nov;66(11):2675-7. doi: 10.1093/jac/dkr329. Epub 2011 Aug 10.

DOI:10.1093/jac/dkr329

PMID:21831987

Abstract

摘要

相似文献

Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.

J Antimicrob Chemother. 2011 Nov;66(11):2675-7. doi: 10.1093/jac/dkr329. Epub 2011 Aug 10.

Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.

J Antimicrob Chemother. 2009 Feb;63(2):357-60. doi: 10.1093/jac/dkn490. Epub 2008 Dec 5.

[Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].

Med Mal Infect. 2008 Dec;38 Spec No 2:10-2. doi: 10.1016/S0399-077X(08)75153-9.

Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.

Chemotherapy. 2010;56(5):411-6. doi: 10.1159/000318057. Epub 2010 Oct 15.

Methicillin-resistant Staphylococcus aureus: the superbug.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S7-11. doi: 10.1016/j.ijid.2010.05.003. Epub 2010 Sep 20.

Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.

J Antimicrob Chemother. 2011 Sep;66(9):2186-8. doi: 10.1093/jac/dkr234. Epub 2011 Jun 8.

Treatment of methicillin-resistant Staphylococcus aureus surgical site infections.

AACN Adv Crit Care. 2011 Jan-Mar;22(1):5-12; quiz 14. doi: 10.1097/NCI.0b013e3181ef86fe2049019.

Drugs for MRSA with reduced susceptibility to vancomycin.

Med Lett Drugs Ther. 2009 May 4;51(1311):36; quiz 37.

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.

Curr Opin Pharmacol. 2010 Oct;10(5):516-21. doi: 10.1016/j.coph.2010.06.006. Epub 2010 Jul 1.

[Staphylococcus aureus and antibiotic resistance].

Mikrobiyol Bul. 2011 Jul;45(3):565-76.

引用本文的文献

Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens.

Ther Adv Infect Dis. 2017 Mar;4(2):49-73. doi: 10.1177/2049936117690501. Epub 2017 Mar 8.

Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.

Drugs. 2015 Dec;75(18):2073-95. doi: 10.1007/s40265-015-0505-8.

Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method.

Antimicrob Agents Chemother. 2015 Jan;59(1):702-6. doi: 10.1128/AAC.04052-14. Epub 2014 Oct 27.

Periprosthetic joint infections: clinical and bench research.

ScientificWorldJournal. 2013 Oct 27;2013:549091. doi: 10.1155/2013/549091. eCollection 2013.

Clinical management of septic arthritis.

Curr Rheumatol Rep. 2013 Jun;15(6):332. doi: 10.1007/s11926-013-0332-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献